Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB)

Forensic Science International

Volumn 245, Issue , 2014, Pages 126-132

  Adamowicz, Piotr ^a   Zuba, Dariusz ^a   Byrska, Bogumiła ^a  

^a INSTITUTE OF FORENSIC RESEARCH   (Poland)

Author keywords

3 MMC; 5 APB; Analysis; Intoxication

Indexed keywords

3 METHYL N METHYLCATHINONE; 5 (2 AMINOPROPYL)BENZOFURAN; ADRENALIN; ALCOHOL; AMPHETAMINE; ATROPINE; BENZOFURAN DERIVATIVE; DIAZEPAM; MIDAZOLAM; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; 3-METHYLMETHCATHINONE; 5-(2-AMINOPROPYL)BENZOFURAN; ALCOHOL BLOOD LEVEL; CENTRAL STIMULANT AGENT; DESIGNER DRUG; METHAMPHETAMINE; PROPYLAMINE;

ADULT; AGITATION; ALCOHOL BLOOD LEVEL; ALCOHOL INTOXICATION; ARTICLE; ARTIFICIAL VENTILATION; AUTOPSY; BLOOD ANALYSIS; BRADYCARDIA; CASE REPORT; CAUSE OF DEATH; CONCENTRATION (PARAMETERS); DEFIBRILLATION; DRUG ABUSE; DRUG INTOXICATION; ECG ABNORMALITY; GLASGOW COMA SCALE; HEART ARREST; HEART MASSAGE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPERTHERMIA; INTUBATION; MALE; SEIZURE; SHOCK; TACHYCARDIA; URINALYSIS; VITAL SIGN; ANALOGS AND DERIVATIVES; BLOOD; DRINKING BEHAVIOR; DRUG DEPENDENCE; DRUG OVERDOSE; FORENSIC TOXICOLOGY; YOUNG ADULT;

ALCOHOL DRINKING; BENZOFURANS; BLOOD ALCOHOL CONTENT; CENTRAL NERVOUS SYSTEM STIMULANTS; DESIGNER DRUGS; DRUG OVERDOSE; FORENSIC TOXICOLOGY; HUMANS; MALE; METHAMPHETAMINE; PROPYLAMINES; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84916237237     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2014.10.016     Document Type: Article

References (39)

1. Zuba D., Byrska B. Prevalence and co-existence of active components of 'legal highs'. Drug Test. Anal. 2013, 5:420-429.
2. Valente M.J., Guedes de Pinho P., de Lourdes Bastos M., Carvalho F., Carvalho M. Khat and synthetic cathinones: a review. Arch. Toxicol. 2014, 88:15-45.
3. Zuba D., Byrska B. Analysis of the prevalence and coexistence of synthetic cannabinoids in herbal high products in Poland. Forensic Toxicol. 2013, 31:21-30.
4. EMCDDA European Drug Report 2013: Trends and Developments, Lisbon 2013, (accessed July, 2014). http://www.emcdda.europa.eu/publications/edr/trends-developments/2013.
5. UNODC The Challenge of New Psychoactive Substances, Vienna 2013, [accessed July, 2014]. http://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf.
6. Hill S.L., Thomas S.H. Clinical toxicology of newer recreational drugs. Clin. Toxicol. (Phila.) 2011, 49:705-719.
7. Miotto K., Striebel J., Cho A.K., Wang C. Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports. Drug Alcohol Depend. 2013, 132:1-12.
8. Mas-Morey P., Visser M.H., Winkelmolen L., Touw D.J. Clinical toxicology and management of intoxications with synthetic cathinones (bath salts). J. Pharm. Pract. 2013, 26:353-357.
9. Wood D.M., Greene S.L., Dargan P.I. Five-year trends in self-reported recreational drugs associated with presentation to a UK emergency department with suspected drug-related toxicity. Eur. J. Emerg. Med. 2013, 20:263-267.
10. (accessed July, 2014). http://www.emcdda.europa.eu/publications/drugnet/online/2011/73/article2.
11. Zuba D., Adamowicz P., Byrska B. Detection of buphedrone in biological and non-biological material - two case reports. Forensic Sci. Int. 2013, 227:15-20.
12. Gil D., Adamowicz P., Skulska A., Tokarczyk B., Stanaszek R. Analysis of 4-MEC in biological and non-biological material - three case reports. Forensic Sci. Int. 2013, 228:e11-e15.
13. European Database on New Drugs. (accessed July, 2014). https://ednd.emcdda.europa.eu/html.cfm/index6555EN.html.
14. Prosser J.M., Nelson L.S. The toxicology of bath salts: a review of synthetic cathinones. J. Med. Toxicol. 2012, 8:33-42.
15. James D., Adams R.D., Spears R., Cooper G., Lupton D.J., Thompson J.P., Thomas S.H. Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service. Emerg. Med. J. 2011, 28:686-689.
16. Wood D.M., Davies S., Greene S.L., Button J., Holt D.W., Ramsey J., Dargan P.I. Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin. Toxicol. (Phila.) 2010, 48:924-927.
17. (accessed July, 2014). http://www.drugs-forum.com/.
18. (accessed July, 2014). http://www.erowid.org/.
19. Adamowicz P., Tokarczyk B., Stanaszek R., Slopianka M. Fatal mephedrone intoxication - a case report. J. Anal. Toxicol. 2013, 37:37-42.
20. Maskell P.D., De Paoli G., Seneviratne C., Pounder D.J. Mephedrone (4-methylmethcathinone)-related deaths. J. Anal. Toxicol. 2011, 35:188-191.
21. Kesha K., Boggs C.L., Ripple M.G., Allan C.H., Levine B., Jufer-Phipps R., Doyon S., Chi P., Fowler D.R. Methylenedioxypyrovalerone (bath salts)-related death: case report and review of the literature. J. Forensic Sci. 2013, 58:1654-1659.
22. Adamowicz P., Gil D., Skulska A., Tokarczyk B. Analysis of MDPV in blood - determination and interpretation. J. Anal. Toxicol. 2013, 37:308-312.
23. Documents from the Public Health Agency of Sweden (not published).
24. Jebadurai J., Schifano F., Deluca P. Recreational use of 1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-pentanone hydrochloride (NRG-1), 6-(2-aminopropyl) benzofuran (benzofury/6-APB) and NRG-2 with review of available evidence-based literature. Hum. Psychopharmacol. 2013, 28:356-364.
25. (accessed July, 2014). http://www.bluelight.org/.
26. Advisory Council on the Misuse of Drugs (ACMD) 6-APB and 5-APB: A Review of the Evidence of Use and Harm, London 2013, (accessed July, 2014). https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/204808/J_TCDO_report_on_5-6APB_and_NBOMe_compounds.pdf.
27. Iversen L. Speed, Ecstasy, Ritalin: The Science of Amphetamines 2008, Oxford University Press, New York.
28. Rothman R.B., Baumann M.H. Monoamine transporters and psychotropic drugs. Eur. J. Pharmacol. 2003, 479:23-40.
29. Dawson P., Opacka-Juffry J., Moffatt J.D., Daniju Y., Dutta N., Ramsey J., Davidson C. The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2014, 48:57-63.
30. Sulzer D., Sonders M.S., Poulsen N.W., Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 2005, 75:406-433.
31. Iversen L., Gibbons S., Treble R., Setola V., Huang X.P., Roth B.L. Neurochemical profiles of some novel psychoactive substances. Eur. J. Pharmacol. 2013, 700:147-151.
32. Davidson C., Ellinwood E.H., Douglas S.B., Lee T.H. Effect of cocaine, nomifensine, GBR 12909 and WIN 35428 on carbon fiber microelectrode sensitivity for voltammetric recording of dopamine. J. Neurosci. Methods 2000, 101:75-83.
33. Martinez-Clemente J., Escubedo E., Pubill D., Camarasa J. Interaction of mephedrone with dopamine and serotonin targets in rats. Neuropsychopharmacology 2012, 22:231-236.
34. Baumann M.H., Ayestas M.A., Partilla J.S., Sink J.R., Shulgin A.T., Daley P.F., Brandt S.D., Rothman R.B., Ruoho A.E., Cozzi N.V. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain. Neuropsychoparmacology 2012, 37:1192-1203.
35. Kehr J., Ichinose F., Yoshitake S., Goiny M., Sievertsson T., Nyberg F., Yoshitake T. Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats. Br. J. Pharmacol. 2011, 164:1949-1958.
36. Molina D.K. Handbook of Forensic Toxicology for Medicinal Examiners 2010, CRC Press.
37. Davidson C., Gow A.J., Lee T.H., Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Rev. 2001, 36:1-22.
38. Levi M.S., Divine B., Hanig J.P., Doerge D.R., Vanlandingham M.M., George N.I., Twaddle N.C., Bowyer J.F. A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during the waking (lights off) cycle. Neurotoxicol. Teratol. 2012, 34:253-262.
39. Brenneisen R., Fisch H.U., Koelbing U., Geisshüsler S., Kalix P. Amphetamine-like effects in humans of the khat alkaloid cathinone. Br. J. Clin. Pharm. 1990, 30:825-828.